Remove companies johnson-johnson
article thumbnail

Health Care Company Johnson & Johnson Announces Merger With Ambrx Biopharma

Benzinga

Johnson & Johnson (NYSE: JNJ ) has announced a merger with Ambrx Biopharma (NASDAQ: AMAM ) that is expected to be completed 2024-H1. Under the terms of the agreement, Johnson & Johnson has agreed to give Ambrx Biopharma $2.00 Ambrx Biopharma Inc is a clinical-stage biologics company.

40
article thumbnail

Talent management: an evolving board imperative

Harvard Corporate Governance

Posted by Matt DiGuiseppe, Maria Moats, and Gregory Johnson, PricewaterhouseCoopers LLP, on Saturday, December 30, 2023 Editor's Note: Matt DiGuiseppe is a Managing Director, Maria Moats is a Leader, and Gregory Johnson is a Director at the Governance Insights Center, PricewaterhouseCoopers LLP.

267
267
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst

Benzinga

Tuesday, Shockwave Medical Inc (NASDAQ: SWAV ) shares traded higher following a Wall Street Journal report suggesting Johnson & Johnson (NYSE: JNJ ) is reportedly in talks to acquire the company. In 2022, Johnson & Johnson acquired heart failure device-focused Abiomed Inc. for an upfront payment of $380.00

article thumbnail

Johnson & Johnson Makes Yet Another Multi-Billion MedTech Deal With Shockwave Medical

Benzinga

Friday, Johnson & Johnson (NYSE: JNJ ) agreed to acquire Shockwave Medical Inc (NASDAQ: SWAV ) for $335.00 The acquisition comes a little more than a year, when in 2022, Johnson & Johnson acquired Abiomed for an upfront payment of $380.00 In November 2023, Johnson & Johnson MedTech acquired Laminar Inc.,

article thumbnail

Freshfields Reps J&J On $13.1B Deal For Shockwave Medical

Law 360 M&A

Freshfields Bruckhaus Deringer-led Johnson & Johnson has agreed to buy Fenwick & West-advised Shockwave Medical Inc., billion, the companies said Friday. a provider of a cardiovascular blood flow treatment, at an enterprise value of $13.1

article thumbnail

DEI Initiatives under Attack by Activists

Harvard Corporate Governance

As early as 2015, activist shareholders have put forth proposals asking companies to implement diversity, equity and inclusion (DEI) policies and to provide more disclosure of the same. Related research from the Program on Corporate Governance includes Social Responsibility Resolutions by Scott Hirst.

Banking 248
article thumbnail

Racial Rhetoric or Reality? Cautious Optimism on the Link Between Corporate #BLM Speech and Behavior

Harvard Corporate Governance

Original research done by this author reveals that by August 2020, 86% of Fortune 100 companies and 66% of Fortune 500 companies released such statements. Johnson & Johnson declared “we must do more. For example, Harley-Davidson insisted: “Racism, hate or intolerance have no place at Harley-Davidson. more…).

188
188